Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A28497 | 12516196 | Clin Liver Dis | The liver in obesity and type 2 diabetes mellitus. | 2002 | Details |
| A28498 | 12508671 | Praxis (Bern 1994) | [Rare, but important chronic liver diseases]. | 2002 | Details |
| A28500 | 12499997 | J Pediatr Gastroenterol Nutr | The spectrum of fatty liver in obese children and the relationship of serum aminotransferases to severity of steatosis. | 2003 | Details |
| A28502 | 12468416 | Best Pract Res Clin Endocrinol Metab | Obesity and liver disease. | 2002 | Details |
| A28507 | 12406446 | Best Pract Res Clin Gastroenterol | Treatment of non-alcoholic steatohepatitis. | 2002 | Details |
| A28508 | 12406445 | Best Pract Res Clin Gastroenterol | Other disease associations with non-alcoholic fatty liver disease (NAFLD). | 2002 | Details |
| A28509 | 12406444 | Best Pract Res Clin Gastroenterol | Interaction of non-alcoholic fatty liver disease with other liver diseases. | 2002 | Details |
| A28510 | 12406443 | Best Pract Res Clin Gastroenterol | Steatohepatitis in children. | 2002 | Details |
| A28511 | 12406442 | Best Pract Res Clin Gastroenterol | Steatohepatitis in obese individuals. | 2002 | Details |
| A28515 | 12406438 | Best Pract Res Clin Gastroenterol | Pathogenesis of steatohepatitis. | 2002 | Details |
| A28518 | 12352254 | Curr Opin Pediatr | Nonalcoholic fatty liver disease (NAFLD) in children. | 2002 | Details |
| A28519 | 12296456 | Nutr Rev | Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. | 2002 | Details |
| A28520 | 12214335 | Rev Gastroenterol Mex | [Non-alcoholic steatohepatitis]. | 2002 | Details |
| A28525 | 12122975 | Rev Gastroenterol Disord | Nonalcoholic fatty liver disease. | 2002 | Details |
| A28527 | 12077098 | Gut | Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. | 2002 | Details |
| A28529 | 12068535 | Arq Gastroenterol | Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation. | 2002 | Details |
| A28532 | 11944631 | Semin Gastrointest Dis | Fat and the liver--a molecular overview. | 2002 | Details |
| A28533 | 11933860 | Versicherungsmedizin | [Nonalcoholic fatty liver]. | 2002 | Details |
| A28534 | 22822324 | Ochsner J | Nonalcoholic Fatty liver disease from the perspective of an internist. | 2002 | Details |
| A28535 | 11915020 | Hepatology | Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. | 2002 | Details |
| A28538 | 11868297 | Obes Surg | Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. | 2002 | Details |
| A28543 | 11751151 | Am J Physiol Gastrointest Liver Physiol | Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. | 2002 | Details |
| A28548 | 11584365 | Hepatology | Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. | 2001 | Details |
| A28552 | 11475019 | Ned Tijdschr Geneeskd | [Abdominal obesity: metabolic complications and consequences for the liver]. | 2001 | Details |
| A28553 | 11473047 | Diabetes | Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. | 2001 | Details |
| A28555 | 11438497 | Gastroenterology | Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. | 2001 | Details |
| A28556 | 11433896 | Obes Surg | Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis? | 2001 | Details |
| A28557 | 11432515 | Dig Liver Dis | Insulin resistance in non-alcoholic steatohepatitis. | 2001 | Details |
| A28558 | 11431335 | Cancer Res | Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? | 2001 | Details |
| A28563 | 11139682 | Gastroenterol Clin Biol | [Cirrhosis with non alcoholic steatohepatitis: role of tamoxifen]. | 2000 | Details |
| A28564 | 11131450 | J Hepatol | Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases. | 2000 | Details |
| A28567 | 10804323 | Diabetes Metab | Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. | 2000 | Details |
| A28568 | 10599403 | Acta Gastroenterol Latinoam | [Steatohepatic cirrhosis in a morbidly obese patient]. | 1999 | Details |
| A28570 | 10422091 | Nutrition | Nutritional and metabolic effects of alcoholism: their relationship with alcoholic liver disease. | 1999 | Details |
| A28585 | 8052745 | Rev Invest Clin | [Non-alcoholic fatty liver: 10 years' experience at the Insituto Nacional de la Nutrición Salvador Zubirán]. | 1994 | Details |
| A28587 | 7658998 | Medicina (B Aires) | [Non alcoholic steatohepatitis]. | 1994 | Details |
| A28595 | 1526433 | Gastroenterol Jpn | Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis. | 1992 | Details |
| A28625 | 35217809 | Acta Pharmacol Sin | FXR: structures, biology, and drug development for NASH and fibrosis diseases. | 2022 | Details |
| A28635 | 35212990 | Methods Mol Biol | Isolation of the Stromal Vascular Fraction from Adipose Tissue and Subsequent Differentiation into White or Beige Adipocytes. | 2022 | Details |
| A28636 | 35212988 | Methods Mol Biol | Mouse Bone Marrow Cell Isolation and Macrophage Differentiation. | 2022 | Details |
| A28672 | 35162986 | Int J Mol Sci | Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease. | 2022 | Details |
| A28697 | 35118457 | touchREV Endocrinol | Non-alcoholic Steatohepatitis: From Pathophysiology to Clinical Practice. | 2021 | Details |
| A28713 | 35103918 | Updates Surg | Combined liver transplantation with sleeve gastrectomy: a pioneer case series from Brazil. | 2022 | Details |
| A28715 | 35102596 | Hepatology | Discovery of a INSIG binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting SREBP-mediated lipogenesis. | 2022 | Details |
| A28730 | 35087844 | Front Med (Lausanne) | An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease. | 2022 | Details |
| A28763 | 35039610 | Lab Invest | High-fat diet-induced nonalcoholic steatohepatitis is accelerated by low carnitine and impaired glucose tolerance in novel murine models. | 2022 | Details |
| A28801 | 34986326 | Cell Chem Biol | An antisense transcript transcribed from Irs2 locus contributes to the pathogenesis of hepatic steatosis in insulin resistance. | 2022 | Details |
| A28817 | 34944770 | Biomedicines | Butyrate Protects against Diet-Induced NASH and Liver Fibrosis and Suppresses Specific Non-Canonical TGF-β Signaling Pathways in Human Hepatic Stellate Cells. | 2021 | Details |
| A28852 | 34910547 | Sci Transl Med | β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development. | 2021 | Details |
| A28895 | 34855620 | J Clin Invest | Dyrk1b promotes hepatic lipogenesis by bypassing canonical insulin signaling and directly activating mTORC2 in mice. | 2022 | Details |
| A28909 | 34833079 | Life (Basel) | Analysis of Differentially Expressed Genes That Aggravate Metabolic Diseases in Depression. | 2021 | Details |
| A28920 | 34813942 | Clin Gastroenterol Hepatol | Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis. | 2021 | Details |
| A28951 | 34782294 | Surg Obes Relat Dis | Impact of metabolic surgery on cost and long-term health outcome: a cost-effectiveness approach. | 2021 | Details |
| A28967 | 34765839 | VideoGIE | Effects of endoscopic gastric plication on portal pressure gradient in a patient with nonalcoholic steatohepatitis cirrhosis. | 2021 | Details |
| A28983 | 34741448 | Hepatol Commun | Dissecting the Balance Between Metabolic and Oncogenic Functions of Astrocyte-Elevated Gene-1/Metadherin. | 2021 | Details |
| A29011 | 34710147 | PLoS One | A systematic review of interventions to promote physical activity in six Gulf countries. | 2021 | Details |
| A29063 | 34638751 | Int J Mol Sci | Anti-Obesity Effect of Polygalin C Isolated from Polygala japonica Houtt. via Suppression of the Adipogenic and Lipogenic Factors in 3T3-L1 Adipocytes. | 2021 | Details |
| A29068 | 34626851 | Mol Metab | GLP-1 physiology informs the pharmacotherapy of obesity. | 2021 | Details |
| A29074 | 34619076 | Cell Metab | "Sweet death": Fructose as a metabolic toxin that targets the gut-liver axis. | 2021 | Details |
| A29086 | 34603061 | Front Pharmacol | Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation. | 2021 | Details |
| A29174 | 34470833 | Saudi Med J | Clinical Practice Guidelines for Liver Transplantation in Saudi Arabia. | 2021 | Details |
| A29185 | 34439245 | Cancers (Basel) | Dietary and Genetic Cholesterol Loading Rather Than Steatosis Promotes Liver Tumorigenesis and NASH-Driven HCC. | 2021 | Details |
| A29207 | 34417537 | Sci Rep | Systemic versus local adipokine expression differs in a combined obesity and osteoarthritis mouse model. | 2021 | Details |
| A29226 | 34390210 | FEBS Open Bio | Nonobese mice with nonalcoholic steatohepatitis fed on a choline-deficient, l-amino acid-defined, high-fat diet exhibit alterations in signaling pathways. | 2021 | Details |
| A29227 | 34386991 | J Labelled Comp Radiopharm | Synthesis of tritium labeled 30-KDa PEG and conjugation to form [3 H]Pegbelfermin. | 2021 | Details |
| A29273 | 34322482 | Front Cell Dev Biol | MicroRNA-494 Regulates Endoplasmic Reticulum Stress in Endothelial Cells. | 2021 | Details |
| A29275 | 34316375 | Gastroenterol Rep (Oxf) | Bariatric surgery proves long-term benefit in patients with cirrhosis. | 2020 | Details |
| A29448 | 34052659 | Biochem Biophys Res Commun | SFPQ associated with a co-activator for PPARγ, HELZ2, regulates key nuclear factors for adipocyte differentiation. | 2021 | Details |
| A29465 | 34027112 | Clin Exp Hepatol | The association between obstructive sleep apnea and non-alcoholic steatohepatitis: a retrospective nationwide inpatient sample analysis. | 2021 | Details |
| A29479 | 34016612 | Diabetes Care | Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study. | 2021 | Details |
| A29484 | 34003688 | Sci Prog | Disease burden of liver cancer attributable to specific etiologies in China from 1990 to 2019: An age-period-cohort analysis. | 2022 | Details |
| A29549 | 33900587 | Obes Surg | Safety and Efficacy of Bariatric Surgery in Advanced Liver Fibrosis. | 2020 | Details |
| A29555 | 33891996 | Cancer Lett | Examining the gut-liver axis in liver cancer using organoid models. | 2021 | Details |
| A29571 | 33859644 | Front Immunol | Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity. | 2021 | Details |
| A29627 | 33783404 | Curr Opin HIV AIDS | Communicable and noncommunicable liver disease in HIV. | 2021 | Details |
| A29659 | 33729641 | J Biochem Mol Toxicol | Differentially expressed proteins obtained by label-free quantitative proteomic analysis reveal affected biological processes and functions in Western diet-induced steatohepatitis. | 2021 | Details |
| A29662 | 33721336 | Aliment Pharmacol Ther | Systematic review with meta-analysis: bariatric surgery reduces the incidence of hepatocellular carcinoma. | 2021 | Details |
| A29749 | 33579422 | Adv Cancer Res | Hepatitis C virus associated hepatocellular carcinoma. | 2020 | Details |
| A29792 | 33513920 | Biomedicines | Magnesium, Little Known But Possibly Relevant: A Link between NASH and Related Comorbidities. | 2021 | Details |
| A29803 | 33490302 | ACG Case Rep J | Intragastric Balloon Improves Steatohepatitis and Fibrosis. | 2021 | Details |
| A29814 | 33465480 | Clin Gastroenterol Hepatol | Predicting Long-term Survival After Liver Transplantation in Patients With NASH Cirrhosis. | 2021 | Details |
| A29839 | 33422984 | Eur J Med Chem | Design of novel Xenopus GLP-1-based dual glucagon-like peptide 1 (GLP-1)/glucagon receptor agonists. | 2020 | Details |
| A29879 | 33344141 | Adv Sci (Weinh) | Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A29919 | 33277568 | Sci Rep | Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects. | 2020 | Details |
| A29923 | 33268008 | Bioorg Chem | Discovery of a novel GLP-1/GIP dual receptor agonist CY-5 as long-acting hypoglycemic, anti-obesity agent. | 2020 | Details |
| A29976 | 33178326 | Evid Based Complement Alternat Med | Efficacy and Mechanism of a Chinese Classic Prescription of Yueju in Treating Nonalcoholic Steatohepatitis and Protecting Hepatocytes from Apoptosis. | 2020 | Details |
| A30049 | 33062352 | Case Rep Gastrointest Med | A Rare Case of Metastatic Hepatocellular Carcinoma Masquerading as a Forehead Hematoma. | 2020 | Details |
| A30134 | 32923834 | Hepatol Commun | The Selective Peroxisome Proliferator-Activated Receptor Gamma Modulator CHS-131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis. | 2020 | Details |
| A30198 | 32833150 | Ann Surg Oncol | The Impact of Modern Chemotherapy and Chemotherapy-Associated Liver Injuries (CALI) on Liver Function: Value of 99mTc-Labelled-Mebrofenin SPECT-Hepatobiliary Scintigraphy. | 2020 | Details |
| A30207 | 32808168 | Obes Surg | Bariatric Surgery in Cirrhotic Patients: a Matched Case-Control Study. | 2020 | Details |
| A30237 | 32764725 | Nat Rev Endocrinol | The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. | 2020 | Details |
| A30300 | 32682196 | Eur J Med Chem | A novel long-acting oxyntomodulin analogue eliminates diabetes and obesity in mice. | 2020 | Details |
| A30407 | 32493884 | Exp Anim | Gender difference in development of steatohepatitis in p62/Sqstm1 and Nrf2 double-knockout mice. | 2020 | Details |
| A30417 | 32473245 | Life Sci | Protective effect of intermediate doses of hydrogen sulfide against myocardial ischemia-reperfusion injury in obese type 2 diabetic rats. | 2020 | Details |
| A30438 | 32443737 | Cancers (Basel) | Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma. | 2020 | Details |
| A30441 | 32441510 | ACS Nano | Targeted Delivery of Notch Inhibitor Attenuates Obesity-Induced Glucose Intolerance and Liver Fibrosis. | 2020 | Details |
| A30445 | 32435609 | J Transl Int Med | Ketogenic, Hypocaloric Diet Improves Nonalcoholic Steatohepatitis. | 2020 | Details |
| A30521 | 32289534 | Clin Gastroenterol Hepatol | Noninvasive Markers of Portal Hypertension Detect Decompensation in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease. | 2020 | Details |
| A30550 | 32247663 | Pharmacol Ther | Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside. | 2020 | Details |
| A30564 | 32205234 | Pharmacol Res | Obesity and NRF2-mediated cytoprotection: Where is the missing link? | 2020 | Details |